Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural Mesothelioma

Condition:   Pleural Mesothelioma Intervention:   Drug: Cadonilimab+Bevacizumab+Pemetrexed+Carboplatin Sponsor:   Sun Yat-sen University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials